5948c85df08ec046fd218614_zenflow.jpg

Zenflow is a biotechnology company that is developing a better treatment for up to 400 million men worldwide who suffer from urinary obstruction related to benign prostatic hyperplasia. It aims to give men a new option that relieves symptoms permanently without requiring a painful, invasive procedure and risking serious complications. Zenflow is currently operating in the clinical stage.